Regeneron Pharmaceuticals, Inc. (REGN) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 80.74B |
| Enterprise Value | 80.33B |
| P/E Ratio | 19.91 |
| PEG Ratio | 63.96 |
| Price/Sales Ratio | 5.53 |
| Price/Book Ratio | 2.72 |
| Enterprise/Revenue | 5.5 |
| Enterprise/EBITDA | 14.86 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | 0.28 |
| Operating Margin | 0.26 |
| Return On Assets | 0.1 |
| Return On Equity | 0.14 |
| Revenue | 14.34B |
| Revenue/Share | 150.24 |
| Gross Profit | 12.24B |
| EBITDA | 5.82B |
| Net Income | 4.5B |
| Diluted EPS | 41.48 |
| Total Cash | 7.99B |
| Total Cash/Share | 77.32 |
| Total Debt | 1.99B |
| Total Debt/Equity | 0.06 |
| Current Ratio | 3.34 |
| Book Value Per Share | 306.68 |
| 52-Week Change | 39.43 |
| 52-Week High | 846.88 |
| 52-Week Low | 541 |
| Moving Average 50 Days | 691.62 |
| Moving Average 200 Days | 723.49 |
| Average Volume | 942,691 |
| Shares Outstanding | 103.02M |
| % Held by Institutions | 88.5 |
| Trailing Annual Dividend Rate | 3.7 |
| Trailing Annual Dividend Yield | 0.44 |
| Payout Ratio | 0.09 |
| Last Split Factor | N/A |
| Last Split Date | N/A |